Why is Trident Texofab falling/rising?

As of 03-Sep, Trident Texofab Ltd's stock is currently priced at Rs 244.00, reflecting a decrease of Rs 5.6, or 2.24%. The stock has been underperforming recently, having fallen consecutively for the last three days, resulting in a total decline of 3.52% during this period. Despite this short-term decline, the stock has shown strong performance over the longer term, with a remarkable increase of 443.31% over the past year and a 45.07% rise year-to-date. The company has reported positive results for the last three consecutive quarters, with net sales growing by 24.20%, which indicates strong operational performance. However, the recent price drop may be attributed to the stock's underperformance against its sector and a slight dip in investor sentiment, despite rising delivery volumes.
In the broader market context, Trident Texofab's short-term performance contrasts with the benchmark Sensex, which has seen a slight decline of 0.27% over the past week. While the stock has outperformed the benchmark in the long term, its recent decline suggests that market conditions may be affecting investor confidence. The stock's liquidity remains adequate, and the majority of shareholders are non-institutional, which could influence trading dynamics. Overall, while the company has demonstrated strong fundamentals, the recent price movement reflects a combination of short-term market pressures and investor sentiment.